DEXIS Receives FDA Clearance for AI Findings on 2D Intraoral X-rays

 DEXIS Receives FDA Clearance for AI Findings on 2D Intraoral X-rays

DEXIS recently received FDA 510(k) Clearance for AI findings on 2D intraoral x-ray images.

DTX Studio Clinic is now the only imaging solution with six types of pathological dental findings on periapical and bitewing intraoral radiograph images and is fully integrated into on-premise imaging software, according to a press release. DTX Studio Clinic is an imaging acquisition, diagnosis and treatment planning software and is part of the DTX Studio suite of products.

DTX Studio Clinic screens dental radiographs and annotates suspected areas of interest, helping clinicians make informed decisions. The six clinical conditions are: caries, discrepancy at margin, root canal defects, periapical radiolucency, bone loss and calculus. DTX Studio Clinic allows clinicians to present patients with a more comprehensive view of the diagnosis and treatment plan, building patient understanding and trust while also driving practice efficiencies.

This most recent clearance complements a series of enhanced AI-powered functionalities in DTX Studio Clinic. In 2017, Envista obtained FDA clearance for its AI-driven 3D virtual tooth setup algorithm. In 2020, clearance was received for automatic tooth position identification and automated sorting of full-mouth x-ray series. In 2022, the FDA cleared fully automated mandibular nerve tracing on CBCT scans. 

View Full Press Release

Source: DEXIS

  • <<
  • >>

Comments

-->